GVR Report cover U.S. Independent Diagnostic Testing Facility Market Size, Share & Trends Report

U.S. Independent Diagnostic Testing Facility Market Size, Share & Trends Analysis Report By Service (Radiology/Imaging Services, Cardiac Monitoring Services, Sleep Studies), And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68040-023-0
  • Number of Pages: 80
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Report Overview

The U.S. independent diagnostic testing facility market was valued at USD 3.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.52% from 2023 to 2030. The growing demand for diagnostic tests, the rising geriatric population, and the increasing burden of chronic diseases are expected to be major drivers for market growth. According to the U.S. Census Bureau, in mid-2019, there were around 54 million Americans in the age group of 65 years and above. This population is expected to reach more than 83 million by 2040.

 U.S. Independent Diagnostic Testing Facility market size, by service, 2020 - 2030 (USD Billion)

Noninvasive diagnostic testing, such as voluntary full-body scans, is gradually being used as a screening tool for precautionary care procedures. Awareness of noninvasive diagnostic testing (X-ray, CT Scan, etc.) among patients as a preventive and less invasive screening method has added to the growth in diagnostic imaging practices. Technological advancements for the early diagnosis of disorders and diseases using less invasive techniques will increase the demand for diagnostic imaging.

Furthermore, growing awareness among people concerning disease management as well as early diagnosis is expected to aid the market growth. The availability of possible cures required for disease conditions coupled with developments in diagnostic tests will boost the demand for radiology tests. Moreover, the rising prevalence of infectious diseases has the potential to impose significant morbidity, death, and financial loss. Over the forecast period, efforts to avoid new infectious diseases will drive market growth.

The market is highly regulated and is subject to various state and federal laws, approvals, and regulations concerning the accreditation and licensing of facilities. All providers offering the technical component of diagnostic MRI, PET/CT, CT, and nuclear medicine must be accredited by 26 CMS authorities (currently the American College of Radiology (ACR), the Intersocietal Accreditation Commission (IAC), and the Joint Commission). The American College of Radiology accredits MRI, CT, nuclear medicine, ultrasound, and mammography institutions. 

The initial months of the COVID-19 pandemic caused a significant drop in the non-COVID-19 business of market players as patients avoided routine medical care and most elective and non-emergency procedures were postponed. Industry players were engaged in increasing testing capacity and developing more coronavirus tests. For instance, LabCorp partnered with the CDC to sequence SARS-CoV-2 and better understand how the coronavirus mutates over time.

Moreover, rapid technological advancements to reduce costs and enhance productivity are expected to enhance the market for independent diagnostic testing facilities (IDTFs) during the forecast period. For instance, in August 2019, the Palmetto Imaging subsidiary of MedQuest Associates announced the acquisition of a controlling interest in ImageCare. The acquisition will increase access for patients to affordable imaging and women’s imaging services in South Carolina.

Service Insights

Based on service, the U.S. IDTF market is categorized into radiological/imaging services, cardiac monitoring services, and sleep studies. The radiology/imaging services segment accounted for the largest revenue share of 57.5% in 2022, due to the availability of services available to reduced cost compared to hospitals. The rising awareness regarding the use of technologically advanced systems has created a demand for these services at IDTFs.

 U.S. Independent Diagnostic Testing Facility market share, by radiology/imaging services, 2022 (%)

The sleep studies segment is expected to witness lower-digit growth during the forecast period. This can be attributed to the less stringent regulations of hospital-based sleep centers and physician-run sleep centers. These services are not limited by stringent regulations and accreditation guidelines such as the Association of Sleep Disorders Centers, the American Academy of Sleep Medicine (AASM), The Joint Commission, and IDTFs.

Moreover, with the growing sleep issues among the population, the demand for sleep studies is rising. According to the CDC statistics, around 32.8% of adults reported short sleep in 2020. Men were the most prevalent population with short sleep duration accounting for around 33.4% of the total men. Lack of sleep leads to various acute health issues which could lead to higher costs of treatments. As per the analysis of Rand Quarterly estimates, in 2020, the projected cost of treating sleep issues in the U.S. was around USD 299 billion to USD 433 billion.

Key Companies & Market Share Insights

The U.S. IDTF market is highly fragmented, and many players are entering the market. Market players are undertaking strategic initiatives to address the increasing demand for imaging services. Key players are acquiring small-sized players to diversify their service offerings and expand their regional footprint. Thus, there is significant competition among market players. For instance, in April 2021, Somology, Inc. launched an independent diagnostic testing facility to cater to the growing demand for sleep studies. Some prominent players in the U.S. independent diagnostic testing facility market include:

  • RadNet, Inc.

  • Vitalistics

  • Breathe

  • Texas MRI

  • The Brookwood Diagnostic Center

  • ACS Diagnostics, Inc.

  • Houston MRI & Diagnostic Imaging

  • TestSmarter Inc.

  • Duke University and Duke University Health System

  • Covenant Health Diagnostics

  • AliveCor, Inc.

  • Advanced Cardio Services

  • Diagnostic Medical Testing Inc.

  • K & T Diagnostic, Inc.

  • Vestavia Diagnostic Center (VDC)

  • Advanced Imaging Center

U.S. Independent Diagnostic Testing Facility Market Report Scope

Report Attribute


Market size value in 2023

USD 3.5 billion

Revenue forecast in 2030

USD 4.8 billion

Growth rate

CAGR of 4.52% from 2023 to 2030

Base year for estimation


Historical data

2018 - 2021

Forecast period

2023 - 2030

Quantitative units

Revenue in USD million and CAGR from 2023 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered


Country scope


Key companies profiled

RadNet, Inc.; Equimed Corporation; Vitalistics; Breathe; Texas MRI; The Brookwood Diagnostic Center; ACS Diagnostics, Inc.; Houston MRI & Diagnostic Imaging; TestSmarter Inc.; Duke University and Duke University Health System; Covenant Health Diagnostics; AliveCor, Inc.; Advanced Cardio Services; Diagnostic Medical Testing Inc.; K & T Diagnostic, Inc.; Vestavia Diagnostic Center (VDC); Advanced Imaging Center

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


U.S. Independent Diagnostic Testing Facility Market Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. independent diagnostic testing facility market report based on services:

  • Service Outlook (Revenue, USD Million, 2018 - 2030)

    • Radiology/Imaging Services

      • X-Ray

      • Computed Tomography (CT)

      • Magnetic Resonance Angiography (MRA)

      • Magnetic Resonance Imaging (MRI)

      • Mammography

      • Ultrasound

      • Positron Emission Tomography (PET) Scan

    • Sleep Studies

    • Cardiac Monitoring Services

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.